523P Camrelizumab plus apatinib as maintenance treatment in patients with extensive-stage small cell lung cancer who were responding or stable after standard first-line chemotherapy (CAMERA): Results from a single-arm, phase II trial
作者
Q.M. Wang,Yue Wu,Qun Wang,Shihong Ma,H. Lu,Yingzhuo Liu